4//SEC Filing
Bizily Scott 4
Accession 0001193125-25-243946
CIK 0001650648other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 7:51 PM ET
Size
8.8 KB
Accession
0001193125-25-243946
Insider Transaction Report
Form 4
Bizily Scott
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-16$4.14/sh+1,635$6,769→ 6,823 total - Sale
Common Stock
2025-10-16$10.17/sh−1,635$16,628→ 5,188 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-16−1,635→ 76,865 totalExercise: $4.14Exp: 2035-03-05→ Common Stock (1,635 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025.
- [F2]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.
Documents
Issuer
4D Molecular Therapeutics, Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001920738
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 7:51 PM ET
- Size
- 8.8 KB